Literature DB >> 20045908

Generation and identification of pluripotent stem cells from human embryonic fibroblast cells by 4 defined factors.

Lili Du1, Ge Lin, Guangxiu Lu.   

Abstract

OBJECTIVE: To generate and identify the induced pluripotent stem cells (iPSCs) from human embryonic fibroblast cells (hEFs) by introducing 4 defined factors.
METHODS: We introduced 4 factors (Oct4, Sox2, Nanog,and Lin28) into hEFs by lentivirus infection. The iPSCs generated from this method were analyzed in many aspects, including surface antigens, gene expression, and telomerase activity, differentiation ability in vivo and in vitro and the patterns of short tandem repeat (STR).
RESULTS: The human iPSCs generated from this study were positive for alkaline phosphatase (AKP) staining, expressed hESCs-specific surface antigens, and exhibited high telomerase activity. They also possessed the ability to differentiate into 3-germ layers both in vivo and in vitro. STR analysis indicated that the human iPSCs were derived from the donor material.
CONCLUSION: The iPSCs lines can be obtained from human embryonic fibroblast by introducing 4 factors. Such human iPSCs should be useful in the study of epigenetic reprogramming and pluripotency maintenance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20045908

Source DB:  PubMed          Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-7347


  2 in total

1.  Transcriptional activation of human CDCA8 gene regulated by transcription factor NF-Y in embryonic stem cells and cancer cells.

Authors:  Can Dai; Cong-Xiu Miao; Xiao-Ming Xu; Lv-Jun Liu; Yi-Fan Gu; Di Zhou; Lian-Sheng Chen; Ge Lin; Guang-Xiu Lu
Journal:  J Biol Chem       Date:  2015-07-13       Impact factor: 5.157

2.  LIN28A marks the spermatogonial progenitor population and regulates its cyclic expansion.

Authors:  Papia Chakraborty; F William Buaas; Manju Sharma; Elizabeth Snyder; Dirk G de Rooij; Robert E Braun
Journal:  Stem Cells       Date:  2014-04       Impact factor: 6.277

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.